Depression News and Research

Latest Depression News and Research

Study finds an exponential increase in older adult opioid overdose death rates

A common stereotype for an "older adult" might include early-bird specials, dentures and tickets to the matinee show.

11 Jan 2022

Study offers new evidence on how childhood immunometabolic risk factors may lead to depression, psychosis

A growing body of research suggests that early-life infection, inflammation, and metabolic changes could contribute to psychiatric disorders – perhaps via effects during critical periods of brain development.

11 Jan 2022

Having children at home may help adults feel less distressed during the pandemic

Kids have struggled throughout the pandemic—from attending school by Zoom video conferencing to quarantining from family and friends—but surprisingly having children at home may help adults feel less distressed.

11 Jan 2022

Ketamine plus psychological therapy can help people stay off alcohol for longer time

People with severe alcohol disorder were able to stay off alcohol for longer when they were treated with low doses of ketamine combined with psychological therapy in a clinical trial.

11 Jan 2022

Real-world effectiveness of three COVID-19 vaccines

Researchers from IQVIA Real-World Solutions have investigated how effective these vaccines are against severe disease.

11 Jan 2022

Psychotropic drugs are commonly used by patients with heart disease, study shows

Antidepressants and other psychiatric medications are associated with an almost doubled risk of premature death in patients with heart conditions, according to research published today in the European Journal of Cardiovascular Nursing, a journal of the European Society of Cardiology (ESC).

11 Jan 2022

Incidence rates of psychiatric diagnoses and drugs in Israeli adolescents before and during the COVID-19 pandemic

Researchers investigated the incidence of psychiatric diagnoses of Israeli adolescents before and during the COVID-19 pandemic.

10 Jan 2022

Researchers discover a potential depression biomarker and why it affects women and men differently

A team of Université Laval scientists may have discovered why severe depression affects women and men differently, according to a study published today in Nature Communications.

10 Jan 2022

Exploring neurodevelopmental effects on infants from in-utero exposure to COVID-19

A new study aimed to determine the associations between fetal exposure to maternal SARS-CoV-2 infection, in-utero, and child neurodevelopmental status.

7 Jan 2022

Study estimates the global prevalence of dementia in 2050

The number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 million in 2050, due primarily to population growth and population aging.

6 Jan 2022

Some heart surgery patients may be able to control postoperative pain without opioids

Many patients who undergo heart surgery may be able to safely and effectively control postoperative pain without opioids after hospital discharge, according to research published online today in The Annals of Thoracic Surgery.

6 Jan 2022

Study examines if antidepressants can benefit patients with osteoarthritis

A clinical trial published in Arthritis & Rheumatology recently examined whether duloxetine, a medication that is prescribed to treat depression and may also reduce chronic pain, can benefit patients with hip or knee osteoarthritis.

6 Jan 2022

Homeschooling improved sleep and health-related quality of life for teenagers

The school closures in spring 2020 had a negative effect on the health and well-being of many young people.

5 Jan 2022

Parents of adolescents get more sleep when middle and high schools start about an hour later

A new study by researchers at National Jewish Health finds that parents of adolescents got more sleep when middle and high schools start about an hour later, while the sleep habits of parents of younger children were unaffected by earlier elementary school start times.

5 Jan 2022

Research demonstrates the safety, feasibility of psilocybin administered at doses of 10mg or 25mg

New research from the Institute of Psychiatry, Psychology, & Neuroscience (IoPPN) at King's College London, in partnership with COMPASS Pathways, has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six participants simultaneously.

4 Jan 2022

Depression screening highly effective at identifying breast cancer patients in need of mental health care

Kaiser Permanente research published January 4, 2022, in JAMA showed depression screening for patients with newly diagnosed breast cancer was highly effective at identifying patients in need of behavioral health care, and the new screening initiative was subsequently and successfully built into the patient care and daily workflow of medical oncology teams at Kaiser Permanente in Southern California.

4 Jan 2022

Researchers identify a biomarker in platelets that tracks the extent of depression

Researchers are one step closer to developing a blood test that provides a simple biochemical hallmark for depression and reveals the efficacy of drug therapy in individual patients.

3 Jan 2022

New treatment method leads to fewer episodes of overeating in patients with morbid obesity

Patients with morbid obesity experienced improvement in their quality of life and distinctly fewer episodes of overeating after ten weeks with a new treatment method developed at NTNU.

3 Jan 2022

Promoting exercise as basic need for managing the physical and cognitive symptoms of MS

Citing recent evidence, experts in rehabilitation research advocate for integrating exercise into the care plans of persons with multiple sclerosis. The central role of the neurologist in clinical care offers an opportunity for this provider to promote exercise as fundamental for managing the physical and cognitive symptoms of MS.

30 Dec 2021

New study targets the methylation profile of microglia from human brain

In the central nervous system, microglial cells play critical roles in development, aging, brain homeostasis, and pathology. Recent studies have shown variation in the gene-expression profile and phenotype of microglia across brain regions and between different age and disease states.

29 Dec 2021

Depression News and Research

Latest Depression News and Research

Study finds an exponential increase in older adult opioid overdose death rates

Study offers new evidence on how childhood immunometabolic risk factors may lead to depression, psychosis

Having children at home may help adults feel less distressed during the pandemic

Ketamine plus psychological therapy can help people stay off alcohol for longer time

Real-world effectiveness of three COVID-19 vaccines

Psychotropic drugs are commonly used by patients with heart disease, study shows

Incidence rates of psychiatric diagnoses and drugs in Israeli adolescents before and during the COVID-19 pandemic

Researchers discover a potential depression biomarker and why it affects women and men differently

Exploring neurodevelopmental effects on infants from in-utero exposure to COVID-19

Study estimates the global prevalence of dementia in 2050

Some heart surgery patients may be able to control postoperative pain without opioids

Study examines if antidepressants can benefit patients with osteoarthritis

Homeschooling improved sleep and health-related quality of life for teenagers

Parents of adolescents get more sleep when middle and high schools start about an hour later

Research demonstrates the safety, feasibility of psilocybin administered at doses of 10mg or 25mg

Depression screening highly effective at identifying breast cancer patients in need of mental health care

Researchers identify a biomarker in platelets that tracks the extent of depression

New treatment method leads to fewer episodes of overeating in patients with morbid obesity

Promoting exercise as basic need for managing the physical and cognitive symptoms of MS

New study targets the methylation profile of microglia from human brain

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Depression News and Research

Latest Depression News and Research

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Newsletters you may be interested in